Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1 × Hyperglycemia × volagidemab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1 Breast 1

Conditions

Hyperglycemia 2 Lymphoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Breast Neoplasms 1

Interventions

volagidemab 2 relacorilant 1 pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04330625 2022-11-08

Glucagon Receptor Inhibition to Enable Breast Cancer Patients to Benefit From PI3K Inhibitor Therapy (REMD-477)

Duke University

Phase 1 Terminated

Breast Neoplasms, Hyperglycemia, Hereditary Sensory and Autonomic Neuropathies

NCT04253223 2021-06-11

A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

Duke University

Phase 1 Terminated

Hyperglycemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡